Articles

Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology

University Medical Center Groningen, The Netherlands
Radboud University Medical Center Nijmegen, The Netherlands
Erasmus MC Cancer Institute, Clinical Trial Center, The Netherlands
VU University Medical Center, Amsterdam, The Netherlands
Academic Hospital Maastricht, The Netherlands
University Hospital Gasthuisberg, Leuven, Belgium
University Medical Center Utrecht, The Netherlands
Erasmus MC, Rotterdam, The Netherlands
University Medical Center Groningen, The Netherlands
Haga Hospitals, Den Haag, The Netherlands
Leiden University Medical Center, The Netherlands
Amsterdam Medical Center, The Netherlands
Antonius Hospital, Nieuwegein, The Netherlands
Erasmus MC Cancer Institute, Clinical Trial Center, The Netherlands
VU University Medical Center, Amsterdam, The Netherlands
Vol. 100 No. 5 (2015): May, 2015 https://doi.org/10.3324/haematol.2014.119198